Shares in Circassia Pharmaceuticals PLC plunged more than 60% after the company said its experimental cat allergy treatment failed to show any advantage over a placebo in a large clinical trial.
from WSJ.com: US Business http://ift.tt/28Il8cl
via IFTTT
No comments:
Post a Comment